Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6273378 | 0.89 | HTT (0.86) | HTTTSHRKMT2AAPEX1LMNA | |
| SCHEMBL10889755 | 0.88 | KMT2A (0.69) | HTTTSHRKMT2AAPEX1LMNA | |
| SCHEMBL28810855 | 0.88 | HTT (0.77) | HTTTSHRKMT2AAPEX1L3MBTL1 | |
| SCHEMBL11089466 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL8963414 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL23610316 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL2638598 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL14483849 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL986325 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA | |
| SCHEMBL23610299 | 0.86 | HTT (0.75) | HTTTSHRLMNAHPGDNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3377492-B1 | CATALYST FOR THE PREPARATION OF POLYURETHANES | BASF SE (DE) | 2022-08-31 | — | — | EP | disclosed |
| CN-108368109-B | Catalyst for preparing polyurethane | 巴斯夫欧洲公司 | 2021-11-23 | — | — | CN | disclosed |
| US-11021560-B2 | Catalyst for the preparation of polyurethanes | BASF SE (DE) | 2021-06-01 | — | — | US | disclosed |
| US-11021560-B2 | Catalyst for the preparation of polyurethanes | BASF SE (DE) | 2021-06-01 | — | — | US | disclosed |
| US-20200172652-A9 | CATALYST FOR THE PREPARATION OF POLYURETHANES | BASF SE (DE) | 2020-06-04 | — | — | US | disclosed |
| US-20200172652-A9 | CATALYST FOR THE PREPARATION OF POLYURETHANES | BASF SE (DE) | 2020-06-04 | — | — | US | disclosed |
| US-20180327534-A1 | CATALYST FOR THE PREPARATION OF POLYURETHANES | BASF SE (CH) | 2018-11-15 | — | — | US | disclosed |
| EP-3377492-A1 | CATALYST FOR THE PREPARATION OF POLYURETHANES | BASF SE (DE) | 2018-09-26 | — | — | EP | disclosed |
| CN-108368109-A | It is used to prepare the catalyst of polyurethane | 巴斯夫欧洲公司 | 2018-08-03 | — | — | CN | disclosed |
| US-20130190491-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | GILEAD SCIENCES, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-4160095-A | PROSTAGLANDINS; ANTIINFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1979-07-03 | — | — | US | disclosed |
| US-4157441-A | PROSTAGLANDINS, ANTIINFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4151351-A | PROSTAGLANDINS, ANTIINFLAMMATORY | THE UPJOHN COMPANY (US) | 1979-04-24 | — | — | US | disclosed |
| US-4131738-A | 6-Hydroxy-PGE1 compounds | THE UPJOHN COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4128713-A | 6,7-Didehydro-PGI1 compounds | THE UPJOHN COMPANY (US) | 1978-12-05 | — | — | US | disclosed |
| US-4126744-A | PROSTACYCLIN, MUSCLE STIMULANTS, PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-4112224-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4109082-A | PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS | THE UPJOHN COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4100192-A | Inter-phenylene-PG amides | THE UPJOHN COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4097489-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180327534-A1 | CATALYST FOR THE PREPARATION OF POLYURETHANES | PUF60, UNG, UMPS | HTT 3621/4885TSHR 4723/4885KMT2A 957/4885 |
| US-20200172652-A9 | CATALYST FOR THE PREPARATION OF POLYURETHANES | PUF60, UNG, UMPS | HTT 3621/4885TSHR 4723/4885KMT2A 957/4885 |
| US-11021560-B2 | Catalyst for the preparation of polyurethanes | PUF60, UNG, UMPS | HTT 3621/4885TSHR 4723/4885KMT2A 957/4885 |
| US-20130190491-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | RTF2, REV1, RTF1 | HTT 3421/4885TSHR 2846/4885KMT2A 2634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.